Target intelligence / Profile preview

3-hydroxyisobutyrate dehydrogenase, mitochondrial (HIBADH)

Target
HIBADH
Molecular classification
Enzyme, Oxidoreductase, Mitochondrial protein, CH-OH group acting with NAD+ or NADP+ as acceptor
01

Overview

3-hydroxyisobutyrate dehydrogenase, mitochondrial (HIBADH), is a tetrameric enzyme located in the mitochondrial matrix that catalyzes the reversible NAD+-dependent oxidation of 3-hydroxyisobutyrate, an intermediate in the valine catabolic pathway, to methylmalonate semialdehyde[4][10][11]. This reaction supports the breakdown of branched-chain amino acids for cellular energy and metabolic homeostasis. HIBADH is highly specific for its substrate and exhibits high stereoselectivity in catalysis. In mammals, HIBADH is also present in spermatozoa, where it is implicated in mitochondrial function and sperm motility, potentially serving as a biomarker for sperm quality[12][13]. Mutations or deficiencies of HIBADH may disrupt normal amino acid metabolism, but there are no current therapies or drugs targeting this enzyme, nor are there recognized safety concerns associated with its function.

Other names
HIBADHNS5ATP1β-hydroxyisobutyrate dehydrogenase3-hydroxyisobutyrate dehydrogenase, mitochondrial3'-hydroxyisobutyrate dehydrogenaseepididymis secretory sperm binding proteinHibadh (mouse/rat ortholog)
02

Mechanism of action

Not applicable (no approved drugs or investigational agents directly target HIBADH)

03

Biological functions

Catalysis of NAD+-dependent reversible oxidation of 3-hydroxyisobutyrate to methylmalonate semialdehydeValine catabolism (branched-chain amino acid degradation)Mitochondrial energy metabolismMaintenance of sperm motility
04

Disease associations

Biomarker for sperm motility/infertility assessmentPotential roles in metabolic diseases affecting branched-chain amino acid metabolism (insufficient evidence for direct involvement in major diseases such as cancer, neurodegeneration, or cardiovascular diseases)
05

Biomarkers

May serve as a sperm-motility marker

Beyond the preview

Go deeper on 3-hydroxyisobutyrate dehydrogenase, mitochondrial (HIBADH).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on 3-hydroxyisobutyrate dehydrogenase, mitochondrial (HIBADH).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call